for The Working Group on Optimizing Medication Therapy in Value-Based Healthca
Articles
July 12th 2012
Role of Pharmaceuticals in Value-Based Healthcare: A Framework for Success
Robert W. Dubois, MD, PhD Marv Feldman, RPh, MS John Martin, MPH Julie Sanderson-Austin, RN Kimberly D. Westrich, MA for The Working Group on Optimizing Medication Therapy in Value-Based Healthca
A framework for the role of pharmaceuticals in value-based healthcare, practical examples from organizations that have made the transition, and implementation considerations.
Latest Updated Articles
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: October 20th 2024 | Updated: November 5th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
Published: November 2nd 2024 | Updated: November 5th 2024
Patients With MDS Disagree With Physicians About Symptom Frequency
Published: February 2nd 2019 | Updated: November 5th 2024
Maternal Deaths, and Disparities, Become a Grassroots Cause
